Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Pfizer gets FDA approval for oncology biosimilar Trazimera
Pharmaceutical Business Review
Tue, 03/12/19 - 11:33 am
Tags:
Pfizer, FDA, Trazimera, Genentech, biosimilars, Herceptin
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
First Word Pharma
Fri, 03/8/19 - 02:27 pm
Tags:
Roche, Genentech, FDA, Tecentriq, triple negative breast cancer
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
BioSpace
Thu, 03/7/19 - 09:56 am
Tags:
artificial intelligence, Roche, Genentech, telemedicine, diabetic macular edema, devices
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Thu, 03/7/19 - 09:53 am
Tags:
Genentech, Roche, AbbVie, chronic lymphocytic leukemia, Gazyva, Venclexta
Thu, 03/7/19 - 09:35 am
Tags:
Genentech, Roche, AbbVie, chronic lymphocytic leukemia, Gazyva, Venclexta
Executive Provides Mentorship and Promotes Diversity at Genentech
BioSpace
Mon, 02/18/19 - 07:44 pm
Tags:
diversity, Genentech, Roche
Layoffs Hit California Biopharma Companies
BioSpace
Mon, 02/18/19 - 11:49 am
Tags:
layoffs, Roche, Genentech, Pfizer, Aduro BioTech, Theravance, Merck
Judge skeptical of JHL's defense in Genentech case
BioCentury
Sat, 02/16/19 - 03:47 pm
Tags:
Genentech, JHL Biotech, trade secrets
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
BioSpace
Mon, 02/11/19 - 11:48 pm
Tags:
Xofluza, Japan, Genentech
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Tue, 02/5/19 - 11:19 pm
Tags:
Genentech, Roche, idiopathic pulmonary fibrosis, Esbriet, generics
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Tue, 02/5/19 - 10:05 am
Tags:
Genentech, Xencor, IL-15, XmAb24306, cancer, bispecific antibodies
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Fri, 02/1/19 - 11:24 am
Tags:
Donald Trump, Medicare Part B, Amgen, Regeneron, Bristol-Myers Squibb, Genentech, Roche
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Sun, 01/27/19 - 07:07 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Thu, 01/24/19 - 11:50 am
Tags:
Genentech, Roche, Alexander Hardy, Pharma CEOs
Samsung Bioepis' First Cancer Biosimilar Approved by the FDA
BioSpace
Mon, 01/21/19 - 11:51 pm
Tags:
FDA, Samsung Bioepis, Ontruzant, biosimilars, Genentech, Herceptin
Gilead, Genentech join PhRMA
BioCentury
Fri, 01/18/19 - 12:03 am
Tags:
PhRMA, Genentech, Gilead Sciences
Genentech Cutting More Jobs in Bay Area
BioSpace
Wed, 01/2/19 - 11:23 am
Tags:
Genentech, Roche, layoffs, Bay Area
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
BioSpace
Mon, 12/17/18 - 08:13 pm
Tags:
Genentech, Proteostasis Therapeutics, small molecule drugs
Genentech develop antibiotic with potential to lead to new class of antibiotics
Pharmaforum
Fri, 12/14/18 - 11:34 am
Tags:
Genentech, G07750, antibiotics, drug development, antibiotic resistance

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.